Atypical Reversible Leucoencephalopathy Syndrome after Bevacizumab/Folfox Regimen for Metastatic Colon Cancer

We are reporting a case of multifocal reversible leucoencephalopathy syndrome induced by chemotherapy based on Folfox-Bevacizumab regimen. A 44-year-old female, with no history of hypertension, received a chemotherapy based on Folfox-Bevacizumab for her metastatic colon cancer (5 FU: 325 mg/m(2) d1...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Case Rep Oncol Med
Main Authors: Salmi, Narimane, Elghissassi, Ibrahim, Bellahammou, Khadija, Lakhdissi, Asmaa, Mrabti, Hind, Errihani, Hassan
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2014
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4221973/
https://ncbi.nlm.nih.gov/pubmed/25400959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/391256
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki